Related references
Note: Only part of the references are listed.Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL
Bodvael Pennarun et al.
JOURNAL OF PATHOLOGY (2013)
Pt(IV) complexes as prodrugs for cisplatin
Yi Shi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules
Anjani Kumar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Are we ready to recommend aspirin for cancer prevention?
Andrew T. Chan et al.
LANCET (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Will an Aspirin a Day Keep Cancer Away?
Jocelyn Kaiser
SCIENCE (2012)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Current status and future prospects for satraplatin, an oral platinum analogue
Hak Choy et al.
CLINICAL CANCER RESEARCH (2008)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin
AS Abu-Surrah et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression
KM Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Update of the preclinical situation of anticancer platinum complexes: Novel design strategies and innovative analytical approaches
M Galanski et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action
GM Li et al.
LABORATORY INVESTIGATION (2002)
Mechanisms of resistance to cisplatin
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
The discovery of aspirin: a reappraisal
W Sneader
BRITISH MEDICAL JOURNAL (2000)
Share Paper
